Pharmacokinetics of doxorubicin co-administered with high-dose verapamil.

The potential for the modification of the pharmacokinetics of doxorubicin (DOX) concurrently administered with high-dose verapamil (VER) has been investigated in 17 patients with advanced neoplasms refractory to drugs belonging to the multidrug resistance spectrum. Steady-state concentration of DOX,...

Descripción completa

Detalles Bibliográficos
Autores principales: Gigante, M., Toffoli, G., Boiocchi, M.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1995
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033454/
https://www.ncbi.nlm.nih.gov/pubmed/7819028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033454/
https://www.ncbi.nlm.nih.gov/pubmed/7819028

Ejemplares similares